Evidence map›Paper›PMID 30405531›Full record

ArticleFrontiers in endocrinology2018

Pharmaceutical Impact of

Jing-Hua Wang, Shambhunath Bose, Na Rae Shin, Young-Won Chin, Young Hee Choi, Hojun Kim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Preventive and Therapeutic Effects ofACS pharmacology & translational science · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Cells · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Buddleoside-RichFrontiers in pharmacology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jing-Hua WangDepartment of Oriental Rehabilitation Medicine, Dongguk University, Goyang, South Korea.
Shambhunath BoseNosQuest, Seongnam-si, South Korea.
Na Rae ShinDepartment of Oriental Rehabilitation Medicine, Dongguk University, Goyang, South Korea.
Young-Won ChinCollege of Pharmacy, Dongguk University-Seoul, Goyang, South Korea.
Young Hee ChoiCollege of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Seoul, South Korea.
Hojun KimDepartment of Oriental Rehabilitation Medicine, Dongguk University, Goyang, South Korea.
Dongguk University · KRNHN (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

endotoxingut microbiotahigh fat dietHouttuynia cordatatype 2 diabetes

Identifiers

PMID30405531
PMCPMC6208002
OpenAlexW2893267893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.